Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
Clinical trial NCT03251768 · COMPLETED
Trial details
- NCT number
- NCT03251768
- Sponsor
- Tianjin SinoBiotech Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-19
- Primary completion
- 2018-07-23
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.